AG-120 in People With IDH1 Mutant Chondrosarcoma

Conditions:   Chondrosarcoma;   Chondrosarcoma, Grade 2;   Chondrosarcoma, Grade 3;   IDH1 Gene Mutation Intervention:   Drug: AG-120 Sponsors:   Memorial Sloan Kettering Cancer Center;   Agios Pharmaceuticals, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials